aap Implantate AG (F:AAQ1) — Stock Price
aap Implantate AG (F:AAQ1) is currently trading at €1.53 EUR, down 6.13% today. Over the past 52 weeks, shares have ranged between €1.27 and €2.22. This page tracks aap Implantate AG's live share price on the F exchange, its daily price and volume history, and — where reported — its income statement, balance sheet, cash flow statement, and earnings history. For company valuation and market capitalisation context, see market value of aap Implantate AG.
aap Implantate AG (AAQ1) Stock Price Chart — Daily History & Trading Volume
The chart below tracks aap Implantate AG's daily closing share price and trading volume on the F exchange over the past year, giving a clear view of recent price momentum and liquidity.
aap Implantate AG Income Statement — Revenue, Profit & Earnings by Year
aap Implantate AG's annual income statement shows how revenue converts into profit each fiscal year, including gross profit, operating income, EBITDA, and net income.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Revenue | €12.20 Million | €11.48 Million | €11.52 Million | €12.17 Million | €9.33 Million |
| Cost of Revenue | €1.53 Million | €1.50 Million | €940.00K | €1.26 Million | €1.37 Million |
| Gross Profit | €10.67 Million | €9.98 Million | €10.58 Million | €10.90 Million | €7.96 Million |
| Research & Development | €103.00K | €233.00K | €223.00K | €246.00K | €290.00K |
| SG&A | €4.70 Million | €4.65 Million | €4.26 Million | €4.55 Million | €4.34 Million |
| Total Operating Expenses | €14.92 Million | €18.53 Million | €14.90 Million | €14.86 Million | €16.95 Million |
| Operating Income | €-2.72 Million | €-7.05 Million | €-3.39 Million | €-2.69 Million | €-7.63 Million |
| EBITDA | — | — | €-1.57 Million | €-520.00K | €-5.40 Million |
| EBIT | — | — | — | €-3.35 Million | €-5.44 Million |
| Interest Expense | €169.00K | €166.00K | €372.00K | €500.00K | €339.00K |
| Income Before Tax | €-3.23 Million | €-7.51 Million | €-3.61 Million | €-2.86 Million | €-8.82 Million |
| Income Tax Expense | — | — | — | €-342.00K | €121.00K |
| Net Income | €-3.63 Million | €-7.96 Million | €-2.56 Million | €-2.70 Million | €-8.79 Million |
aap Implantate AG Balance Sheet — Assets, Liabilities & Shareholder Equity
The balance sheet below summarizes aap Implantate AG's financial position at each fiscal year-end — what it owns (assets), what it owes (liabilities), and the resulting shareholder equity.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Total Assets | €15.84 Million | €17.28 Million | €20.23 Million | €22.95 Million | €19.71 Million |
| Total Current Assets | €8.88 Million | €8.11 Million | €11.18 Million | €13.32 Million | €10.53 Million |
| Cash & Equivalents | — | — | — | — | — |
| Short-term Investments | €392.00K | €363.00K | €268.00K | €191.00K | €292.00K |
| Net Receivables | €1.95 Million | €2.00 Million | €2.57 Million | €3.10 Million | €1.82 Million |
| Inventory | €4.09 Million | €4.07 Million | €7.82 Million | €7.32 Million | €6.96 Million |
| Property, Plant & Equipment | — | — | — | €5.21 Million | €4.68 Million |
| Goodwill | — | — | — | — | — |
| Total Liabilities | €5.38 Million | €9.18 Million | €7.40 Million | €10.18 Million | €9.41 Million |
| Total Current Liabilities | €4.53 Million | €4.79 Million | €5.52 Million | €6.34 Million | €5.01 Million |
| Long-term Debt | €69.00K | €2.79 Million | €0.00 | €938.00K | €2.58 Million |
| Net Debt | — | €2.07 Million | €911.00K | €288.00K | €1.87 Million |
| Total Stockholder Equity | €10.46 Million | €8.10 Million | €12.83 Million | €12.78 Million | €10.29 Million |
| Retained Earnings | €-31.37 Million | €-27.64 Million | €-19.71 Million | €-17.10 Million | €-14.58 Million |
aap Implantate AG Cash Flow Statement — Operating, Investing & Financing Activities
This cash flow statement breaks down how aap Implantate AG generates and spends cash across operating, investing, and financing activities each fiscal year, including free cash flow and capital expenditures.
| Fiscal Year | 2024 | 2023 | 2022 | 2021 | 2020 |
|---|---|---|---|---|---|
| Operating Cash Flow | €-1.12 Million | €-2.92 Million | €-1.89 Million | €-2.47 Million | €-3.67 Million |
| Capital Expenditures | €330.00K | €406.00K | €485.00K | €329.00K | €334.00K |
| Free Cash Flow | €-1.45 Million | €-3.32 Million | €-2.38 Million | €-2.99 Million | €-4.09 Million |
| Investing Cash Flow | — | — | — | €155.00K | €-140.00K |
| Financing Cash Flow | — | — | — | €3.53 Million | €1.77 Million |
| Dividends Paid | — | — | — | — | — |
| Stock-Based Compensation | €0.00 | €3.00K | €-15.00K | €18.00K | €-5.00K |
| Depreciation | €1.86 Million | €4.07 Million | €1.67 Million | €1.43 Million | €2.10 Million |
| Change in Cash | €773.00K | €1.04 Million | €-1.88 Million | €1.23 Million | €-2.05 Million |
aap Implantate AG Earnings History — EPS Actual vs. Analyst Estimates
Track aap Implantate AG's quarterly earnings per share (EPS) against Wall Street estimates, along with the earnings surprise percentage for each reporting period.
| Report Date | EPS Actual | EPS Estimate | Surprise |
|---|---|---|---|
| Aug 18, 2025 | — | — | — |
| Jun 02, 2025 | — | — | — |
| Feb 13, 2025 | — | — | — |
| Nov 14, 2024 | — | — | — |
| Aug 14, 2015 | -0.05 | — | — |
| May 11, 2011 | -0.10 | 0.50 | -120.00% |
| Nov 05, 2010 | 0.10 | 0.50 | -80.00% |